Company Information
CIN
Status
Date of Incorporation
20 February 2007
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2011
Last Annual Meeting
13 August 2011
Paid Up Capital
200,000,000
Authorised Capital
200,000,000
Directors
Venkateswarlu Jasti
Director/Designated Partner
over 2 years ago
over 2 years ago
Ravula Sayisiva Prasad
Managing Director
almost 19 years ago
almost 19 years ago
Past Directors
Subba Rao Parupalli
Additional Director
over 16 years ago
over 16 years ago
Patents
The present invention provides a taste masked orally disintegrating composition, preferably an orally disintegrating tablet of Imatinib or pharmaceutically acceptable salt thereof, comprising a) Imatinib or pharmaceutically acceptable salts thereof, b) a taste-masking polymer, c) a super disintegrant and optionally ...
The present invention provides the pharmaceutical capsule formulation comprising the compound pellets consisting of Dipyridamole and Acetyl salicylic acid and the process for preparing the same.
The present invention provides a pharmaceutical tablet, comprising Imatinib in an amount of 50-75%w/w of the total tablet weight and comprising atleast one pharmaceutically acceptable excipient without a binding agent and the process for preparation of the same.
The present invention relates to an orally disintegrate tablet which comprises (i) the granules having an average particle diameter of more than 400µm which granules comprise a composition coated by an enteric coating layer comprising an enteric coating agent and viscosity imparting agent and (ii) an additive.
...
The present invention relates to the orally disintegrating tablets of Zolmitriptan comprising the Zolmitriptan as an active ingredient and a stabilizer.
The present invention relates to Pharmaceutical capsule comprising the tablet, pellets or granules comprising (i) a core ii) the first drug layer comprising 30-90% of Dexlansoprazole of the total weight of the Dexlansoprazole filled into the capsules iii) a first sub coating layer iv) an extended release layer compr...
The present invention relates to the stable pharmaceutical composition comprising levodopa, carbidopa, entacapone or pharmaceutically acceptable salts or hydrates thereof and a stabilizer. The invention also relates to the process of preparing said stable pharmaceutical composition.
The present invention relates to the pharmaceutical composition comprising two discrete portions of the mixtures of levodopa, carbidopa and entacapone or pharmaceutically acceptable salts or hydrates thereof and the process for preparing the same.
Registered Trademarks
[Class : 5] Medicinal And Pharmaceutical Preparations; Veterinary And Sanitary Preparations
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
Documents
Form 21-280812.PDF
Copy of the Court-Company Law Board Order-280812.PDF
Form 21-040812.PDF
Copy of the Court-Company Law Board Order-040812.PDF
Form 23B for period 010411 to 310312-300811.OCT
Optional Attachment 4-240412.PDF
Optional Attachment 2-240412.PDF
Optional Attachment 3-240412.PDF
Optional Attachment 1-240412.PDF
Form 2-310112.OCT
Resltn passed by the BOD-300112.PDF
List of allottees-300112.PDF
Form 22B-240112-230112.PDF
Declaration by person-240112.PDF
Form 32-210112.OCT
Optional Attachment 1-200112.PDF
Evidence of cessation-200112.PDF
Form 32-200112.OCT
Optional Attachment 2-190112.PDF
Optional Attachment 1-190112.PDF
XBRL document in respect of balance sheet 25-11-2011 for the financial year ending on 31-03-2011.pdf.PDF
Form 23AC XBRL-281111-251111 for the FY ending on-310311.OCT
FormSchV-191111 for the FY ending on-310311.OCT
Form 23B for period 010410 to 310311-101010.OCT
Form 2-270511.OCT
Resltn passed by the BOD-260511.PDF
List of allottees-260511.PDF
Form 5-230511.PDF
Form 23-230511.PDF
MoA - Memorandum of Association-230511.PDF
